GlassScriptPhysician profile
Angela M Reining
NPI 1043352263
$1,608.73
in general payments reported to CMS, 2019-2025
21 companies · $36.14 in 2025
The $36.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $130 · 2021: $320 · 2022: $327 · 2023: $340 · 2024: $114 · 2025: $36.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $539.28 | 2019-2025 | |
| Coopersurgical, INC. | $221.52 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Evofem Biosciences, INC. | $202.66 | 2021-2023 | Phexxi |
| Organon LLC | $100.52 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $73.80 | 2022-2024 | Aptima, Third Wave, Thinprep 2000 Processor |
| Astellas Pharma US INC | $65.93 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $62.39 | 2019-2022 | |
| Lupin INC. | $47.98 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $38.45 | 2021-2022 | |
| Allergan, INC. | $31.78 | 2019-2020 | |
| Agile Therapeutics, INC. | $29.94 | 2022-2023 | Twirla |
| Merck Sharp & Dohme LLC | $28.34 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $27.80 | 2019 | |
| Covidien LP | $26.56 | 2019 | |
| Sumitomo Pharma America, INC. | $21.85 | 2023 | Myfembree |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $17.46 | 2021 | |
| Mayne Pharma Commercial LLC | $16.28 | 2021 | |
| Minerva Surgical, INC | $16.08 | 2023 | |
| Vertical Pharmaceuticals, LLC | $14.84 | 2019 | |
| Axonics, INC. | $13.12 | 2023 | Axonics |
| Pfizer INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Reining listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.